Effectiveness of inactivated influenza vaccine for prevention of otitis media in children

The Pediatric Infectious Disease Journal
Senem Konuk OzgurHakan Tuzun

Abstract

The objective of this study was to evaluate the effectiveness of inactivated influenza vaccine in preventing acute otitis media (AOM) and otitis media with effusion (OME) in children aged 6 to 60 months who attend day care. This prospective, single-blind study was conducted in 8 day care centers in Ankara, Turkey. One hundred nineteen (61 vaccinated and 58 unvaccinated against influenza) healthy children were examined at study entry and at 6-week intervals for 6 months by the same 2 otorhinolaryngologists who were blinded about the vaccination status of the children. The frequency of AOM and OME is compared between the 2 groups and the effect of influenza season on frequency of episodes was evaluated. Based on national influenza laboratory data, the influenza season was determined to be the period between December 15, 2003, and January 31, 2004. The frequencies of AOM, OME and total otitis media episodes in vaccinated children were 2.3%, 22.8% and 25.2%, respectively, and these frequencies were 5.2%, 31.1% and 36.3% in the unvaccinated group. The difference was statistically significant (P < 0.01). This difference was especially prominent in the influenza season (P < 0.05). Influenza vaccine is effective in reducing AOM and OME...Continue Reading

References

Apr 1, 1991·American Journal of Diseases of Children·T HeikkinenP Halonen
Apr 1, 1988·The Journal of Pediatrics·E R WaldF Taylor
Jul 1, 1986·Reviews of Infectious Diseases·F W DennyF W Henderson
Jul 1, 1986·Reviews of Infectious Diseases·F W Henderson, G S Giebink
Jun 10, 1982·The New England Journal of Medicine·F W HendersonF W Denny
May 1, 1980·The Annals of Otology, Rhinology & Laryngology. Supplement·D W TeeleB A Rosner
Oct 1, 1995·Archives of Pediatrics & Adolescent Medicine·D A ClementsE Walter
Jan 28, 1999·The New England Journal of Medicine·T HeikkinenT Chonmaitree
May 23, 2000·The Pediatric Infectious Disease Journal·R B Belshe, W C Gruber
Feb 13, 2001·Vaccine·T Heikkinen
May 3, 2002·Pediatrics·Birgit WintherJ Owen Hendley
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paola MarchisioNicola Principi
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Alejandro HobermanJill D Kerr

❮ Previous
Next ❯

Citations

Sep 21, 2011·The Journal of Infectious Diseases·Kirsty R ShortOdilia L Wijburg
Apr 28, 2009·The Pediatric Infectious Disease Journal·Humberto Bracco NetoUNKNOWN D153-P504 LAIV Study Group
May 11, 2013·European Journal of Pediatrics·Bernhard R Ruf, Markus Knuf
May 10, 2012·Future Microbiology·Kirsty R ShortDimitri A Diavatopoulos
Oct 12, 2012·European Journal of Pediatrics·Bahar Cuhaci ÇakirAli Özdek
Nov 15, 2013·Influenza and Other Respiratory Viruses·Jane C Deng
Nov 4, 2015·Pediatrics in Review·Jose Rosa-OlivaresIran Niroomand-Rad
May 23, 2018·Human Vaccines & Immunotherapeutics·Kathrin U Jansen, Annaliesa S Anderson
May 2, 2007·Current Opinion in Infectious Diseases·Mary IskanderStephen Lambert
Aug 31, 2010·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Lorry G Rubin
Jan 10, 2018·Nature Medicine·Kathrin U JansenAnnaliesa S Anderson
Sep 14, 2012·Expert Review of Respiratory Medicine·David Paul MooreShabir Ahmed Madhi
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Tom JeffersonEliana Ferroni
Dec 19, 2018·Proceedings of the National Academy of Sciences of the United States of America·Keith P Klugman, Steven Black
Feb 2, 2018·The Cochrane Database of Systematic Reviews·Tom JeffersonVittorio Demicheli
Sep 12, 2014·Expert Review of Vaccines·Ioanna ChristopoulouXavier Saelens
Jul 28, 2010·Pediatrics·Lorry G RubinUNKNOWN Committee on Infectious Diseases and Section on Otolaryngology-Head and Neck Surgery
Feb 27, 2013·Pediatrics·Allan S LieberthalDavid E Tunkel
Apr 3, 2008·Pediatrics·UNKNOWN American Academy of Pediatrics Committee on Infectious Diseases

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.